The ALLHAT Report: a Case of Information and Misinformation

Overview

Journal J Clin Hypertens (Greenwich)

Specialty Cardiology & Vascular Diseases

Date 2003 Jan 31

PMID 12556647

Citations 8

Authors

Michael A Weber

Affiliations

Soon will be listed here.

Citing Articles

Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension.

Spoladore R, Maranta F, Fragasso G Indian Heart J. 2017; 69(3):417.

PMID: 28648446 PMC: 5485400. DOI: 10.1016/j.ihj.2017.01.002.

Varenicline: quantifying the risk.

Blankfield R CMAJ. 2011; 183(12):1404.

PMID: 21896706 PMC: 3168633. DOI: 10.1503/cmaj.111-2062.

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Davis B, Kostis J, Simpson L, Black H, Cushman W, Einhorn P Circulation. 2008; 118(22):2259-67.

PMID: 19001024 PMC: 2775475. DOI: 10.1161/CIRCULATIONAHA.107.762229.

Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics.

Palatini P J Clin Hypertens (Greenwich). 2005; 7(2):96-101.

PMID: 15722654 PMC: 8109366. DOI: 10.1111/j.1524-6175.2005.03793.x.

[The ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial): primary antihypertensive agents - diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors].

Scholze J, Unger T Internist (Berl). 2003; 44(9):1193-5.

PMID: 14566471 DOI: 10.1007/s00108-003-1028-z.

References

Hansson L, Zanchetti A, Carruthers S, Dahlof B, Elmfeldt D, Julius S . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998; 351(9118):1755-62. DOI: 10.1016/s0140-6736(98)04311-6. View

Brenner B, Cooper M, de Zeeuw D, Keane W, Mitch W, Parving H . Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345(12):861-9. DOI: 10.1056/NEJMoa011161. View

Materson B, Reda D, Cushman W, Massie B, FREIS E, Kochar M . Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993; 328(13):914-21. DOI: 10.1056/NEJM199304013281303. View

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-13. DOI: 10.1016/s0140-6736(02)11911-8. View

Lewis E, Hunsicker L, Bain R, Rohde R . The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993; 329(20):1456-62. DOI: 10.1056/NEJM199311113292004. View